Neurocutaneous Melanocytosis Registry

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

September 3, 2027

Study Completion Date

September 3, 2027

Conditions
Cutaneous Melanocytic NeoplasmLarge Cutaneous Melanocytic NeviNeurocutaneous Melanocytosis
Trial Locations (2)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

02115

NOT_YET_RECRUITING

Boston Children's Hospital (Data Analysis Only), Boston

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER